Dimensional Fund Advisors LP Buys 1,089,923 Shares of Envista Holdings Co. (NYSE:NVST)

Dimensional Fund Advisors LP boosted its position in Envista Holdings Co. (NYSE:NVST - Free Report) by 19.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,762,091 shares of the company's stock after acquiring an additional 1,089,923 shares during the quarter. Dimensional Fund Advisors LP owned 3.93% of Envista worth $130,440,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of NVST. Treasurer of the State of North Carolina increased its stake in Envista by 0.6% in the 4th quarter. Treasurer of the State of North Carolina now owns 75,560 shares of the company's stock worth $1,458,000 after purchasing an additional 480 shares during the period. Amalgamated Bank boosted its holdings in shares of Envista by 0.7% during the fourth quarter. Amalgamated Bank now owns 80,380 shares of the company's stock worth $1,551,000 after purchasing an additional 523 shares during the period. GAMMA Investing LLC grew its stake in shares of Envista by 30.5% in the fourth quarter. GAMMA Investing LLC now owns 2,304 shares of the company's stock worth $44,000 after purchasing an additional 538 shares during the last quarter. M&T Bank Corp increased its holdings in Envista by 4.2% during the 4th quarter. M&T Bank Corp now owns 16,621 shares of the company's stock valued at $320,000 after purchasing an additional 676 shares during the period. Finally, Assetmark Inc. raised its position in Envista by 2.5% during the 4th quarter. Assetmark Inc. now owns 39,624 shares of the company's stock valued at $764,000 after purchasing an additional 983 shares during the last quarter.

Envista Price Performance

NVST stock traded down $0.34 during mid-day trading on Wednesday, hitting $15.86. The company had a trading volume of 1,844,131 shares, compared to its average volume of 2,508,832. The company has a market capitalization of $2.69 billion, a price-to-earnings ratio of -2.44, a P/E/G ratio of 1.27 and a beta of 1.12. The company has a 50-day moving average price of $17.00 and a 200 day moving average price of $19.08. The company has a quick ratio of 1.76, a current ratio of 2.04 and a debt-to-equity ratio of 0.44. Envista Holdings Co. has a 12-month low of $14.22 and a 12-month high of $23.00.

Envista (NYSE:NVST - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $0.24 EPS for the quarter, topping the consensus estimate of $0.23 by $0.01. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. On average, research analysts anticipate that Envista Holdings Co. will post 1 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Piper Sandler reduced their target price on Envista from $18.00 to $17.00 and set a "neutral" rating on the stock in a research note on Wednesday. Morgan Stanley set a $16.00 price objective on shares of Envista in a research report on Tuesday, April 15th. Jefferies Financial Group raised their target price on shares of Envista from $20.00 to $22.00 and gave the stock a "hold" rating in a research report on Thursday, January 23rd. New Street Research set a $19.00 target price on shares of Envista in a research note on Thursday, March 6th. Finally, UBS Group lowered their price objective on shares of Envista from $23.00 to $21.00 and set a "neutral" rating for the company in a report on Monday, March 10th. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and an average target price of $20.18.

Envista Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.